Connection
Michael Bishop to Doxorubicin
This is a "connection" page, showing publications Michael Bishop has written about Doxorubicin.
|
|
Connection Strength |
|
|
|
|
|
0.041 |
|
|
|
-
Mascarenhas L, Ogawa C, Laetsch TW, Weigel BJ, Bishop MW, Krystal J, Borinstein SC, Slotkin EK, Muscal JA, Hingorani P, Levy DE, Mo G, Shahir A, Wright J, DuBois SG. Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors. Cancer Med. 2021 02; 10(3):843-856.
Score: 0.041